Company Performance Metrics
- Charles Mbata: Co-Founder
MetalDrug Revolutionizing Molecular Engineering Through Deterministic Logic
Overview MetalDrug is a next-generation molecular design platform pioneering a new field: Deterministic Logic-Driven Molecular Engineering (DLME). Anchored by our proprietary systems - MDC (Metal Drug Complexes), FDC (Functional Drug Complexes), and the Moleculogic Engine
- we convert molecular simulation into structured, logic-verified therapies.
Our Mission To eliminate trial-and-error in drug development by replacing probabilistic discovery with deterministic, logic-validated compound engineering - creating safer, smarter, and faster paths to novel therapeutics.
Core Technologies
MDC: Metal-coordinated therapeutic complexes designed with switch-like behavior for ROS, pH, and other microenvironmental triggers.
FDC: Expands beyond metals into proteins, non-metal ligands, and functional assemblies for broader biochemical applications.
Moleculogic: A tiered simulation and scoring engine built to reason, validate, and evolve compounds based on first principles - integrating SEI logic for traceable, reproducible therapeutic design.
What Makes Us Different
No black-box AI. Every molecule is logic-traced, simulation-audited, and scientifically explainable.
Tiered access model - from open preview to closed scientific sandbox and industry-grade simulation.
Live generation and validation of compounds and blueprints, scored continuously by SEI-lite and SEI-core systems.
Our Advantage Where AlphaFold predicted form, MetalDrug engineers function - governed by principles of rational constructivism and self-validating AI. This is not another bio-AI. This is the new logic of life.